Blended learning for entrepreneurial biomedical professionals

Paul Janssen Futurelab Leiden offers a non-profit, international blended learning program for tomorrow’s leaders in biomedical science who have the ambition to develop a new medical intervention.

Our participants

Learn more about our participants

On campus

On-campus experience

Further explore the concepts of the online courses during the on-campus course. Maximum 30 participants are invited to castle Oud-Poelgeest near Leiden, the Netherlands to work in small, multidisciplinary focus groups on advanced teaching cases that are based on real R&D project.


Read more

A selection of our contributors

Marc Martens

Marc Martens

Head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels


Bird & Bird

Aliki Nichogiannopoulou

Aliki Nichogiannopoulou

Director


European Patent Office

Bruno Vandermeulen

Bruno Vandermeulen

IP Lawyer - Member of the Brussels Bar


Independent IP practitioner

On-campus

Nacer Lounis

Nacer Lounis

Senior Principal Scientist


Janssen Pharmaceutica

On-campus

Tine de Marez

Tine de Marez

Senior Director, Compound Development Team Leader TB


Johnson & Johnson

Bert Leufkens

Bert Leufkens

Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board


Utrecht Institute for Pharmaceutical Sciences (UIPS)

Henk Schuring

Henk Schuring

VP-Head Rare Nephrology


Sanofi Genzyme

Sjaak Bot

Sjaak Bot

VP, Head of EMEA Regulatory Affairs


Janssen

Bernd van der Meulen

Bernd van der Meulen

Professor of Comparative Food Law


European Institute for Food Law / Renmin University of China Law School

Frank Landolt

Frank Landolt

Chief Counsel Legal & Intellectual Property


Confo Therapeutics

On-campus

Erik Niks

Erik Niks

Neurologist - Pediatric neurologist


Leiden University Medical Center

On-campus

Piet Hinoul

Piet Hinoul

Global Head, Pre-Clinical, Clinical and Medical Affairs


J&J Ethicon

On-campus

Ad Sitsen

Ad Sitsen

Owner


ClinPharMed Consultancy for Drug Development

Eline Bunnik

Eline Bunnik

Assistant professor Medical Ethics and Philosophy of Medicine


Erasmus MC

Maurits Westerik

Maurits Westerik

IE/IT lawyer


Coupry

Bart Swinkels

Bart Swinkels

Partner


NLO

Karin Verzijden

Karin Verzijden

Food and Pharma Lawyer


Axon Lawyers

On-campus

Ineke Jonker-Hoogerkamp

Ineke Jonker-Hoogerkamp

Consultant Regulatory Affairs and Drug Development


Paul Janssen Futurelab & Eagle Pharma Consult

Kees Recourt

Kees Recourt

Investment Manager


Mibiton Foundation

Paul Stoffels

Paul Stoffels

Chief scientific officer


Johnson & Johnson

Tom Huizinga

Tom Huizinga

Head of the Department of Rheumatology


Leiden University Medical Centre

On-campus

Marcel Kenter

Marcel Kenter

Director


Paul Janssen Futurelab Leiden

On-campus

Koen Andries

Koen Andries

VP Scientific Fellow Infectious Diseases Discovery


Janssen Pharmaceutica NV

On-campus

Andreas Wallnöfer

Andreas Wallnöfer

General Partner


BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)

On-campus

Justin Hay

Justin Hay

Pharmacokinetics Assessor


Medicines and Healthcare products Regulatory Agency

On-campus

André Elferink

André Elferink

Clinical epidemiologist


Dutch Medicines Evaluation Board

On-campus

Rob Zuiker

Rob Zuiker

Senior Clinical Scientist


CHDR

On-campus

Barbara J. van Zwieten-Boot

Barbara J. van Zwieten-Boot

Vice Chair


Medicines Evaluation Board, The Netherlands

Hans-Georg Eichler

Hans-Georg Eichler

Senior Medical Officer


European Medicines Agency

On-campus

Robert Klautz

Robert Klautz

Thoracic Surgeon


Leiden University Medical Centre

On-campus

Matthijs Moerland

Matthijs Moerland

Research Director Translational Biomarkers


CHDR

Joris Rotmans, MD, PhD

Joris Rotmans, MD, PhD

internist-nephrologist


LUMC

On-campus

Janneke Meulenberg

Janneke Meulenberg

CEO


Arthrogen

Inge de Lepeleire

Inge de Lepeleire

Director Translational Pharmacology


MSD Europe

On-campus

Koos Burggraaf

Koos Burggraaf

Research Director CVS & Metabolism


CHDR

Johan Garssen

Johan Garssen

Director Immunology Platform


Danone/Nutricia Research

On-campus

Ingrid de Visser

Ingrid de Visser

Senior Clinical Scientist


CHDR

Rick Kuntz

Rick Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer


Medtronic

On-campus

Geert Jan Groeneveld

Geert Jan Groeneveld

Research Director CNS


CHDR

Oliver Bisazza

Oliver Bisazza

Director Regulatory Policy


Medtronic

Saco de Visser

Saco de Visser

Teacher and Clinical Pharmacologist


Paul Janssen Futurelab Leiden

On-campus

Adam Cohen

Adam Cohen

CEO and clinical pharmacologist


Centre for Human Drug Research

Richard Shull

Richard Shull

Head of Deal Structuring and Trading Fundamentals


Shell

Pierre Peeters

Pierre Peeters

Former site head early stage development


Organon

Quote Paul Janssen Futurelab

Really instructive

"The highlights of the course were the real life examples and the follow up provided. The interviews with people that were involved in the studies were really instructive"

Georges Habineza Ndikuyeze, Janssen Research & Development, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Excellent learning opportunities

“The cases were excellent and the manner in which they were presented provided excellent learning opportunities”

Vickas Patel, GlaxoSmithKline, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Not the traditional classroom

"Clinical development was dissected in a different way than I am used to, which was intriguing. The interface of the online course and exam were really nice: simple and straightforward to interact with, at your own pace and time, and you can go back and forth as you wish, certainly not the traditional way of a frontal classroom interface!”

Ofer Spiegelstein, Teva Pharmaceutical Industries Ltd, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Happy with responses

“Real life case studies and learning about 'how it really happened'. Very happy with responses on comments (timewise and content)”

Joost van Middendorp, Pfizer, Clinical Development Online graduate

Recent tweets

Twitter image

LUMC constructs the largest stem cell facility for the Netherlands and beyond https://t.co/WcAweEjvUs @LUMC #NECSTGEN https://t.co/WcAweEjvUs

Twitter image

A few days left to sign up for the online course of May 4th. Participants rate this course 9 out of 10. Learn how Question Based Clinical Development can optimize the development of medical products and how to apply it to real R&D projects. https://t.co/M2DQ3uViLE

In collaboration with CCMO, Futurelab offers a FREE COURSE about legislation and procedures on clinical research in the Netherlands. Brush up on how to submit your research file with this short animation. https://t.co/WkF0I0IP3E